肝细胞癌可能的治疗方法

N. Yadav
{"title":"肝细胞癌可能的治疗方法","authors":"N. Yadav","doi":"10.53390/ijbs.v12.i1.7","DOIUrl":null,"url":null,"abstract":"Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide. HCC patients are diagnosed in advanced stages, due to its poor prognosis. Currently, immunotherapy and chemotherapy are the best treatment options in >90 cases of liver cancer. Therefore, new treatment options are urgently needed for the cure of liver cancer. Use of nanotechnology and/or some natural compounds may become better options for liver cancer patients with minimum side effects and lower toxicity. This review focuses on present available treatment approaches for the management of liver cancer in patients.","PeriodicalId":219235,"journal":{"name":"International Journal on Biological Sciences","volume":"56 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"POSSIBLE TREATMENT APPROACHES FOR HEPATOCELLULAR CARCINOMA\",\"authors\":\"N. Yadav\",\"doi\":\"10.53390/ijbs.v12.i1.7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide. HCC patients are diagnosed in advanced stages, due to its poor prognosis. Currently, immunotherapy and chemotherapy are the best treatment options in >90 cases of liver cancer. Therefore, new treatment options are urgently needed for the cure of liver cancer. Use of nanotechnology and/or some natural compounds may become better options for liver cancer patients with minimum side effects and lower toxicity. This review focuses on present available treatment approaches for the management of liver cancer in patients.\",\"PeriodicalId\":219235,\"journal\":{\"name\":\"International Journal on Biological Sciences\",\"volume\":\"56 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal on Biological Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.53390/ijbs.v12.i1.7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal on Biological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53390/ijbs.v12.i1.7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

肝细胞癌(HCC)是世界上最常见的肝脏恶性肿瘤。HCC患者由于预后较差,诊断为晚期。目前,免疫治疗和化疗是90例肝癌患者的最佳治疗选择。因此,迫切需要新的治疗方案来治愈肝癌。使用纳米技术和/或一些天然化合物可能成为肝癌患者的更好选择,副作用最小,毒性较低。本文综述了目前肝癌患者的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
POSSIBLE TREATMENT APPROACHES FOR HEPATOCELLULAR CARCINOMA
Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide. HCC patients are diagnosed in advanced stages, due to its poor prognosis. Currently, immunotherapy and chemotherapy are the best treatment options in >90 cases of liver cancer. Therefore, new treatment options are urgently needed for the cure of liver cancer. Use of nanotechnology and/or some natural compounds may become better options for liver cancer patients with minimum side effects and lower toxicity. This review focuses on present available treatment approaches for the management of liver cancer in patients.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信